Bacterial Efflux Pumps and Their Inhibitors

Anti-Infectives
Helen I. Zgurskaya

Helen I. Zgurskaya

University of Oklahoma, Norman, OK, USA

Search for more papers by this author
Valentin V. Rybenkov

Valentin V. Rybenkov

University of Oklahoma, Norman, OK, USA

Search for more papers by this author
John K. Walker

John K. Walker

Saint Louis University School of Medicine, St. Louis, MO, USA

Search for more papers by this author
Jerry M. Parks

Jerry M. Parks

Oak Ridge National Laboratory, Oak Ridge, TN, USA

Search for more papers by this author
First published: 28 April 2021
Citations: 1

Abstract

Bacterial multidrug efflux transporters have distinct molecular features and mechanisms that enable their impressive substrate polyspecificity. These transporters are involved in all physiological processes where nonspecific but active transport across membranes is critical for survival and proliferation. Importantly, efflux pumps contribute to bacterial virulence and pathogenesis, as well as the spread of antibiotic resistance in clinics. Transporters belonging to several protein superfamilies have been selected for polyspecificity by evolution and augmented with accessory proteins that extend and couple transport reactions across the inner and outer membranes of the bacterium. As a result, bacteria are equipped with diverse efflux machines that protect cells from a broad variety of toxic compounds including antibiotics and other small molecule therapeutics. The inhibition of such polyspecific biomolecular machines is a challenging task, which still awaits an efficient solution. Here, we review the molecular mechanisms of efflux pumps from Gram-negative bacteria and recent advances and challenges associated with the discovery of effective inhibitors of these pumps.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.